Zeitschrift für Phytotherapie 2010; 31(5): 247-250
DOI: 10.1055/s-0030-1262396
Forschung
Restless-legs-Syndrom
© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Das Restless-legs-Syndrom (RLS) – Erfahrungsbericht mit einem Vitex agnus-castus (VAC)-Extrakt

Axel Brattström, Wolf-Dietrich Kaiser
Further Information

Publication History

Publication Date:
08 November 2010 (online)

Zusammenfassung

Ethanolische Extrakte der Früchte von Vitex agnus-castus (VAC) wirken als gemischter Dopamin-D2/D3-Rezeptoragonist. Das RLS wird therapiert mit Dopaminagonisten. Ein erster Therapieversuch mit einem standardisierten VAC-Extrakt, d.h. mit einem pflanzlichen Dopaminagonisten, an einer kleinen Patientenzahl (n = 12) ergab vielversprechende Ergebnisse, die durch systematische Untersuchungen zu verifizieren sind.

Summary

The restless legs syndrome. First experiences with an extract from Vitex agnus-castus Ethanolic extracts from the fruits of Vitex agnus-castus (VAC) act as a mixed D2/D3 receptor agonist. Dopamine agonists are first line therapy for restless legs syndrome (RLS). In a small group of patients (n = 12) suffering from RLS a standardized VAC extract was tested as a dopamine agonist derived from plants for the first time. The outcome is promising and further clinical trials should be stimulated.

Literatur

  • r1 Baker WL. White CM. Coleman CI. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome.  Ann Fam Med. 2008;  6 253-262
  • r2 Barriere G. Cazalets JR. Bioulac B. , et al. The restless legs syndrome.  Prog Neurobiol. 2005;  77 139-165
  • r3 Brattström A. Meier B. Dimpfel W. CNS dopamine agonist action of the Vitex agnuscastus extract Ze 440 in freely moving, chronically instrumented animals.  Z Phytother. 2008;  29 ((Suppl. 1)) S5-S6
  • r4 Brattström A. Use of Vitex agnus castus extracts for preparing a medicament. 2009 Patent Internal Application No.: PTC/EP2008/007051
  • r5 Collins GT. Witkin JM. Newman AH. , et al. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behaviour.  J Pharmacol Exp Ther. 2005;  314 310-319
  • r6 Collins GT. Newman AH. Grundt P. , et al. Yawning and hyperthermia in rats: effect of dopamine D3 and D2 agonists and antagonists.  Psychopharmacol. 2007;  193 159-170
  • r7 Daniele C. Coon JT. Pittler MH. Ernst E. Vitex agnus castus. A systematic review of adverse events.  Drug Safety. 2005;  28 319-332
  • r8 Hoberg E. Orjala J. Meier B. Sticher O. Diterpenoids from the fruits of Vitex agnus-castus. .  Phytochemistry. 1999;  52 1555-1558
  • r9 Hoberg E. Meier B. Sticher O. Quantitative high performance liquid chromatographic analysis of casticin in the fruits of Vitex agnus-castus. .  Pharmaceutical Biol. 2001;  39 57-61
  • r10 Jarry H. Leonhardt S. Wuttke W. , et al. Agnus castus als dopaminerges Wirkprinzip in Mastodynon N.  Z Phytother. 1991;  12 77-82
  • r11 Jarry H. Spengler B. Wuttke W. Christoffel V. In vitro assays for bioactivity-guided isolation of endocrine active compounds in Vitex agnus-castus. .  Maturitas. 2006;  55 S26-S36
  • r12 Joyce JN. Millan MJ. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease.  Curr Opin Pharmacol. 2007;  7 100-105
  • r13 van Kampen JM. Robertson HA. A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra.  Neuroscience. 2005;  136 381-386
  • r14 van Kampen JM. Eckman CB. Dopamine D3 receptor agonist delivery to a model of Parkinson's diseases restores the nigrostriatal pathway and improves locomotor behaviour.  J Neuroscience. 2006;  26 7272-7280
  • r15 Kushida C. Martin M. Nikam P. , et al. Burden of restless legs syndrome on health-related quality of life.  Qual Life Res. 2007;  16 617-624
  • r16 Medcalf P. Bhatia KP. Restless legs syndrome.  BMJ. 2006;  333 457-458
  • r17 Meier B. Berger D. Hoberg E. , et al. Pharmacological activities of Vitex agnus-castus extracts in vitro.  Phytomedicine. 2000;  7 373-381
  • r18 Millan MJ. Seguin L. Gobert A. , et al. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.  Psychopharmacology. 2004;  174 341-357
  • r19 Paulus W. Dowling P. Rijsman R. , et al. Pathophysiological concepts of restless legs syndrome.  Mov Disord. 2007;  22 1451-1456
  • r20 Rizzo V. Arico I. Mastroeni C. , et al. Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome.  Mov Disord. 2009;  24 710-705
  • r21 Satija P. Ondo W. Restless legs syndrome: Pathopysiology, diagnosis and treatment.  CNS Drugs. 2008;  22 497-518
  • r22 Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.  BMJ. 2001;  322 134-137
  • r23 Simmen U. Löchner C. Jordan M. et al. Multiple batch affinity of a chaste tree (Vitex agnus castus L.) extract (Ze 440) to dopamine D3 receptors. 51st Annual Congress Medicinal Plant Research, 31.8.–4.9.2003 Kiel, Germany. Book of Abstracts: p 199
  • r24 Diener HC. Putzki N. Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. 4. Aufl. Stuttgart; Thieme 2008: 56-67

Prof. Dr. Axel Brattström



Alexander Puschkin Str. 50

39108 Magdeburg

Email: Axel.Brattstroem@t-online.de

Priv.-Doz. Dr. Wolf-Dietrich Kaiser



Nordhäuser Str. 1

99089 Erfurt

Email: info@doktor-kaiser.de

Online

http://dx.doi.org/10.1055/s-0030-1262396

    >